Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-3-8
pubmed:abstractText
Apelin, the proposed endogenous peptide ligand of the novel G-protein-coupled receptor APJ, has been shown to possess potent vasodilator and positive inotropic effects in rats and humans in vivo. However, in humans, no endogenous source of apelin has been reported. Therefore, based on the presence of APJ and mRNA encoding apelin in human tissues, we investigated the expression of apelin in fresh-frozen human tissue from right atrium, left ventricle, lung, kidney, adrenal and large conduit vessels using immunocytochemistry. Apelin-like immunoreactivity (apelin-LI) was detected in vascular endothelial cells lining blood vessels in the human heart, kidney, adrenal gland and lung and in endothelial cells of large conduit vessels. Apelin-LI was also present in endocardial endothelial cells lining recesses of the right atrium. Apelin-LI was not present or below the level of detection in cardiomyocytes, Purkinje's cells, pulmonary or renal epithelial cells, secretory cells of the adrenal gland, vascular smooth muscle cells, adipocytes, nerves and connective tissue. The restricted presence of apelin-LI in endothelial cells suggests that endothelial apelin may play a role as a locally secreted cardiovascular mediator acting on APJ receptors present on the vascular smooth muscle and on cardiac myocytes to regulate vascular tone and cardiac contractility.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0167-0115
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
118
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
119-25
pubmed:dateRevised
2011-6-15
pubmed:meshHeading
pubmed-meshheading:15003827-Adrenal Glands, pubmed-meshheading:15003827-Antibodies, pubmed-meshheading:15003827-Carrier Proteins, pubmed-meshheading:15003827-Coronary Vessels, pubmed-meshheading:15003827-Cross Reactions, pubmed-meshheading:15003827-Endocardium, pubmed-meshheading:15003827-Endothelial Cells, pubmed-meshheading:15003827-Endothelium, Vascular, pubmed-meshheading:15003827-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:15003827-Hemodynamics, pubmed-meshheading:15003827-Humans, pubmed-meshheading:15003827-Immunohistochemistry, pubmed-meshheading:15003827-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:15003827-Kidney, pubmed-meshheading:15003827-Lung, pubmed-meshheading:15003827-Models, Biological, pubmed-meshheading:15003827-Myocardium, pubmed-meshheading:15003827-Peptide Fragments, pubmed-meshheading:15003827-Receptors, G-Protein-Coupled, pubmed-meshheading:15003827-Saphenous Vein, pubmed-meshheading:15003827-von Willebrand Factor
pubmed:year
2004
pubmed:articleTitle
Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells.
pubmed:affiliation
Clinical Pharmacology Unit, University of Cambridge, Level 6, Centre for Clinical Investigation, Box 110, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK. mk395@medschl.cam.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't